Healthcare Reform
Featured Topics
Lead story
Other featured articles
-
Economic Incentives for Administrative Simplification
In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.
Posted in -
Private Equity Investment as a Divining Rod for Market Failure: Policy Responses to Harmful Physician Practice Acquisitions
It is unclear whether private equity investment is itself a problem or whether, in the absence of private equity, other sources of capital—such as public equity, venture capital, health systems, and insurers—would similarly exploit existing market failures and legal loopholes in the healthcare system.
Posted in -
Medical Device Regulation and Reimbursement: What the Pandemic Revealed
Join Schaeffer Center for a discussion on the challenges and opportunities facing the FDA and CMS in an age of breakthrough medical devices.
Posted in -
Medicare Coverage of Innovative Technologies: The U.S. Should do More to Speed Entry of Breakthrough Devices to Market
Schaeffer Center Expert Joe Grogan provides background on the proposed rule – Medicare Coverage of Innovative Technologies (MCIT) – and argues eliminating MCIT would abandon attempts to jumpstart American medical device innovation while also denying patients quick access to technologies that can improve their lives and their health.
Posted in
About this section
Healthcare reform should hinge on improving value, reducing waste, and bettering the health outcomes of patients. The Schaeffer Center is a pioneer in posing solutions to enhance the value of healthcare services and expand their reach.
Our Experts On Healthcare Reform
Our Work In Healthcare Reform
-
Federal Government Should Advise on Drug Negotiations, Not Run Them
Schaeffer Center experts Karen Mulligan and Darius Lakdawalla argue that the Department of Health and Human Services should help advice drug price negotiations instead of running them.
Categorized in -
Changes in Emergency Physician Service Prices After Connecticut’s 2016 Surprise Billing Law
On January 1, 2022, the No Surprises Act will take effect. This study aims to fill that knowledge gap by presenting preliminary evidence about the effects of Connecticut’s 2016 surprise billing law on the emergency physician services market.
Categorized in -
Setting the Stage for the Next 10 Years of Health Care Payment Innovation
Nonresident Senior Fellow Bob Kocher describes four health policy strategies that could unlock large improvements in healthcare cost and quantity.
Categorized in -
Comments On a CMS Proposal to Allow Year-Round Marketplace Enrollment for Low-Income People
Schaeffer Initiative expert Matthew Fiedler provided comments to the Centers for Medicare and Medicaid Services on proposed rule that would permit people with incomes below 150% of the federal poverty level (FPL) to enroll in coverage through the Health Insurance Marketplaces established by the Affordable Care Act at any time during the year, rather than solely during the annual open enrollment period.
-
Comments on the Development of a Public Health Insurance Option
Schaeffer Initiative experts Matthew Fiedler and Loren Adler provided comments in response to a request for information on the design of a public health insurance option from the chairs of the House Energy and Commerce Committee and Senate Health, Education, Labor, and Pensions Committee.
-
Drug Rebates in Medicare Part D
On July 27, the USC-Brookings Schaeffer Initiative for Health Policy will host a webinar to discuss how the increasing reliance on rebates burdens many Medicare patients and policy solutions.
Categorized in